Age Related Insulin Signaling Decline

Age related insulin signaling decline refers to progressive impairment in cellular responsiveness to insulin with advancing age. Insulin signaling regulates glucose uptake, energy storage, and metabolic coordination across tissues. During aging, insulin receptor sensitivity decreases in muscle, liver, and adipose tissue due to inflammation, lipid accumulation, and mitochondrial dysfunction. This decline disrupts downstream signaling cascades, reducing glucose utilization and promoting hyperglycemia. Age related insulin signaling decline contributes to metabolic instability, increased fat accumulation, and elevated risk of diabetes and cardiovascular disease. Chronic low-grade inflammation and altered nutrient sensing amplify signaling impairment. Importantly, insulin signaling decline reflects biological aging rather than chronological age alone. Understanding this process provides insight into how aging disrupts metabolic communication and highlights insulin sensitivity as a central determinant of metabolic health and aging resilience.